# PRECLINICAL TOXICOLOGY OF LARGE MOLECULE DRUGS DEVELOPED FOR CANCER AND OTHER INDICATIONS

> **NIH NIH N01** · IIT RESEARCH INSTITUTE · 2023 · $1,456,819

## Abstract

Preclinical Toxicology of Large Molecule Drugs Developed for Cancer and Other Indications.

## Key facts

- **NIH application ID:** 10802090
- **Project number:** 75N91022C00010-P00002-9999-1
- **Recipient organization:** IIT RESEARCH INSTITUTE
- **Principal Investigator:** DAVID MCCORMICK
- **Activity code:** N01 (R01, R21, SBIR, etc.)
- **Funding institute:** NIH
- **Fiscal year:** 2023
- **Award amount:** $1,456,819
- **Award type:** —
- **Project period:** 2022-04-01 → 2023-03-31

## Primary source

NIH RePORTER: https://reporter.nih.gov/project-details/10802090

## Citation

> US National Institutes of Health, RePORTER application 10802090, PRECLINICAL TOXICOLOGY OF LARGE MOLECULE DRUGS DEVELOPED FOR CANCER AND OTHER INDICATIONS (75N91022C00010-P00002-9999-1). Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/grant/nih/10802090. Licensed CC0.

---

*[NIH grants dataset](/datasets/nih-grants) · CC0 1.0*